Real World Safety of Tarlatamab Step-Up Dosing in Extensive Stage Small Cell Lung Cancer
Real World Safety of Tarlatamab Step-Up Dosing in Extensive Stage Small Cell Lung Cancer is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Real World Safety of Tarlatamab Step-Up Dosing in Extensive Stage Small Cell Lung Cancer have?
Real World Safety of Tarlatamab Step-Up Dosing in Extensive Stage Small Cell Lung Cancer has 2 citations in the OpenAlex counts ScholarIQ stores.
When was Real World Safety of Tarlatamab Step-Up Dosing in Extensive Stage Small Cell Lung Cancer published?
Real World Safety of Tarlatamab Step-Up Dosing in Extensive Stage Small Cell Lung Cancer has 2025 year in the ScholarIQ index.
What is the open-access status of Real World Safety of Tarlatamab Step-Up Dosing in Extensive Stage Small Cell Lung Cancer?
Real World Safety of Tarlatamab Step-Up Dosing in Extensive Stage Small Cell Lung Cancer has closed oa status in the ScholarIQ index.
What is the DOI of Real World Safety of Tarlatamab Step-Up Dosing in Extensive Stage Small Cell Lung Cancer?
The DOI for Real World Safety of Tarlatamab Step-Up Dosing in Extensive Stage Small Cell Lung Cancer is on the source record.
What is the OpenAlex record for Real World Safety of Tarlatamab Step-Up Dosing in Extensive Stage Small Cell Lung Cancer?
The OpenAlex for Real World Safety of Tarlatamab Step-Up Dosing in Extensive Stage Small Cell Lung Cancer is on the source record.